Antiphospholipid Antibodies in Patients with COVID-19
Patients infected with COVID-19 are at higher risk of thrombosis, suggesting an important role of COVID-19 induced coagulopathy. Abnormal coagulation parameters such as elevation in D-dimer are found in patients, with frequent thrombotic events ranging from peripheral ischemia, pulmonary thromboembo...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74377 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Antiphospholipid Antibodies in Patients with COVID-19
- Bleeding in Patients with Antiphospholipid Antibodies
- Presence of Antibodies Against Mycoplasma penetrans in Patients with Antiphospholipid Syndrome
- Antiphospholipid Antibodies – Detection and Clinical Importance
- The Management of Antiphospholipid Antibodies Affected Pregnancy
- Update on Antiphospholipid Antibody Syndrome Management
- Antiphospholipid Antibodies and Their Association with Atherosclerotic Changes in Patients with Systemic Lupus Erythematosus – Review of Literature and Own Experiences